Aurinia Pharmaceuticals (AUPH) Long-Term Deferred Tax (2025 - 2026)

Aurinia Pharmaceuticals (AUPH) has 2 years of Long-Term Deferred Tax data on file, last reported at $166.9 million in Q1 2026.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $166.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $166.9 million (changed N/A YoY) and the FY2025 annual result came in at $176.2 million, changed N/A from the prior year.
• Long-Term Deferred Tax slipped to $166.9 million in Q1 2026, from $176.2 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $176.2 million in Q4 2025 to a low of $166.9 million in Q1 2026.